Search results for "Highlights"


 
Results 31 - 40 of about 248 for "Highlights".
Sort by: Relevance | Newest | Oldest

Undiagnosed liver disease frequently found among patients with cognitive impairment

Among 177,422 veterans with dementia and no prior cirrhosis diagnosis, 10.3% had a Fibrosis-4 score suggestive of advanced fibrosis and 5.3% had a score suggestive of cirrhosis.
https://gastroenterology.acponline.org/archives/2024/02/23/3.htm
23 Feb 2024

Serum ferritin values may improve risk stratification of MASLD patients

Baseline hyperferritinemia occurred in almost one-third of study patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and was associated with higher stages of fibrosis.
https://gastroenterology.acponline.org/archives/2024/01/26/3.htm
26 Jan 2024

Cyclic vomiting syndrome affects 42 per 100,000 Medicaid beneficiaries, study finds

Within 30 days of diagnosis of cyclic vomiting syndrome, only 32% to 35% of adult patients had prescriptions for prophylactic treatment and 47% to 55% for acute treatment, according to an industry-funded study of U.S. claims databases.
https://gastroenterology.acponline.org/archives/2024/01/26/2.htm
26 Jan 2024

Spotlight on treatment response in Crohn's disease

Recent studies evaluated early versus late response to biologic therapy, treatment response and infection risk, and endoscopic outcomes.
https://gastroenterology.acponline.org/archives/2024/01/26/5.htm
26 Jan 2024

AGA issues guidance on diet, nutrition in IBD

A new clinical practice update from the American Gastroenterological Association (AGA) covers the role of diet and nutritional therapies in managing inflammatory bowel disease (IBD) and identifying and treating malnutrition in IBD patients.
https://gastroenterology.acponline.org/archives/2024/02/23/1.htm
23 Feb 2024

For ulcerative colitis, ustekinumab safe, effective through 4 years, industry study finds

Most patients who had symptomatic remission of their ulcerative colitis on the drug maintained it without corticosteroids, an extension of a randomized trial found.
https://gastroenterology.acponline.org/archives/2023/12/22/3.htm
22 Dec 2023

In symptomatic adults undergoing high-resolution manometry, long-term opioid use was linked to esophageal dysmotility

The results of a recent meta-analysis highlight the need for clinicians to widen their perspective on the risks of opioids to include both upper and lower GI motility disorders, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2023/12/22/8.htm
22 Dec 2023

No-biopsy approach can diagnose celiac disease in select adults

IgA anti-tissue transglutaminase levels of at least 10 times the upper limit of normal have a sensitivity of 51% and specificity of 100% for predicting celiac disease in adults referred to secondary care, a meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/01/26/1.htm
26 Jan 2024

Thalidomide reduced bleeding in patients with small-intestinal angiodysplasia

A total of 68.6% of patients who were randomized to 100 mg of thalidomide daily (taken in four doses a day) had a reduction of at least 50% in bleeding episodes in the year after treatment compared to 16% of those on placebo.
https://gastroenterology.acponline.org/archives/2023/12/22/2.htm
22 Dec 2023

Low-dose amitriptyline appears effective as second-line treatment for IBS

Patients with irritable bowel syndrome (IBS) who were randomized to titrated doses of a tricyclic antidepressant had significant improvements in their IBS symptom scores at six months compared to those receiving a placebo, a trial in primary care found.
https://gastroenterology.acponline.org/archives/2023/10/27/2.htm
27 Oct 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next